Related references
Note: Only part of the references are listed.NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022
Craig Horbinski et al.
Journal of the National Comprehensive Cancer Network (2023)
Molecular and clinical diversity in primary central nervous system lymphoma
I. Hernandez-Verdin et al.
ANNALS OF ONCOLOGY (2023)
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network
Marion Alcantara et al.
BLOOD (2022)
MYD88L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy
Rongrong Chen et al.
Therapeutic Advances in Hematology (2022)
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
Matthew J. Frigault et al.
BLOOD (2022)
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elias Campo et al.
BLOOD (2022)
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
Inka Puhakka et al.
BMC CANCER (2022)
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial
Andres J. M. Ferreri et al.
LEUKEMIA (2022)
Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant
Natalie L. Wu et al.
BLOOD ADVANCES (2022)
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study
Caroline Houillier et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio et al.
LEUKEMIA (2022)
Expression of Cas9 in a Syngeneic Model of Primary Central Nervous System Lymphoma Induces Intracerebral NK and CD8 T Cell-Mediated Lymphoma Cell Lysis Via Perforin
Manuel Montesinos-Rongen et al.
CRISPR JOURNAL (2022)
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
Gerald Illerhaus et al.
BLOOD (2022)
CXCR4, CXCR5 and CD44 May Be Involved in Homing of Lymphoma Cells into the Eye in a Patient Derived Xenograft Homing Mouse Model for Primary Vitreoretinal Lymphoma
Neele Babst et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
Sabela Bobillo et al.
HAEMATOLOGICA (2021)
Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma
Yoshitaka Narita et al.
NEURO-ONCOLOGY (2021)
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?
Osnat Bairey et al.
ACTA HAEMATOLOGICA (2021)
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
M. K. Gandhi et al.
BLOOD (2021)
Exome sequencing identifies SLIT2 variants in primary CNS lymphoma
Leon D. Kaulen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Implementation of Inpatient Palliative Care Consultation Triggers and Its Impact on Healthcare Use in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Jenny J. Xiang et al.
BLOOD (2021)
Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study
Alexandra L. Farrall et al.
CANCERS (2021)
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
Andres J. M. Ferreri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)
Ramon F. Barajas et al.
NEURO-ONCOLOGY (2021)
MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial
Andrés J M Ferreri et al.
Lancet Haematology (2021)
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
Michael Scordo et al.
JAMA ONCOLOGY (2021)
Breaching the Blood-Brain Tumor Barrier for Tumor Therapy
Fabrizio Marcucci et al.
CANCERS (2021)
Primary vitreoretinal lymphoma: a diagnostic and management challenge
Carole Soussain et al.
BLOOD (2021)
Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of CALGB 51101 (Alliance).
Tracy Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma
Marco Fangazio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL
Alexander Baraniskin et al.
CANCERS (2021)
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice
Elisabeth Schorb et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma
Prakash Ambady et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma
Csaba Bodor et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Timothy J. Kaufmann et al.
NEURO-ONCOLOGY (2020)
Management and outcome of primary CNS lymphoma in the modern era An LOC network study
Caroline Houillier et al.
NEUROLOGY (2020)
Expression of the ghrelin/growth hormone secretagogue receptor axis and its functional role in promoting tumor growth in primary central nervous system lymphomas
Hiroko Muta et al.
NEUROPATHOLOGY (2020)
Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14
Jaewoo Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Eye involvement in primary central nervous system lymphoma
Alexandra L. Farrall et al.
SURVEY OF OPHTHALMOLOGY (2020)
PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma
Motomasa Furuse et al.
BMC CANCER (2020)
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival
Nicolas Martinez-Calle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
George W. Wright et al.
CANCER CELL (2020)
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy
Lukas Marcelis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).
Antonio Marcilio Padula Omuro et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study
Marc Bertaux et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
The Efficacy and Safety of Cytarabine on Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
Xiaohong Zheng et al.
FRONTIERS IN ONCOLOGY (2020)
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study
Elisabeth Schorb et al.
BLOOD ADVANCES (2020)
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
Andres J. M. Ferreri et al.
BLOOD ADVANCES (2020)
Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition
Isabel Jimenez et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study
R. Velasco et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas
Jerrold L. Boxerman et al.
NEURO-ONCOLOGY (2020)
Phase 1 Study of Escalating Doses of Ibrutinib and Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) with Isavuconazole for Relapsed and Refractory Primary CNS Lymphoma
Mark Roschewski et al.
BLOOD (2020)
HIV prevalence in primary central nervous system lymphoma: A systematic review and meta-analysis
Raduan Ahmed Franca et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient
Shixing Bao et al.
MAGNETIC RESONANCE IN MEDICAL SCIENCES (2019)
MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA
Elisabetta Miserocchi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)
Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease
Frederic Pouzoulet et al.
BLOOD CELLS MOLECULES AND DISEASES (2019)
Low-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma
Khoan Vu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data
Dima Dandachi et al.
CANCER CAUSES & CONTROL (2019)
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
Andres J. M. Ferreri et al.
BLOOD (2019)
Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma
Geraldine Faivre et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study
Caroline Houillier et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells
Yasuo Takashima et al.
BMC CANCER (2019)
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention
Tracy O'Connor et al.
CANCER CELL (2019)
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis
Andreas M. Schmitt et al.
HEMATOLOGICAL ONCOLOGY (2019)
Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation
Denise D. Correa et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice
Matthias Mulazzani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type
Anahita Nosrati et al.
ANNALS OF HEMATOLOGY (2019)
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Christian Grommes et al.
BLOOD (2019)
Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma
Christopher P. Fox et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
Jacoline E. C. Bromberg et al.
LANCET ONCOLOGY (2019)
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma
Christian Grommes et al.
NEURO-ONCOLOGY (2019)
CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Sanfang Tu et al.
FRONTIERS IN ONCOLOGY (2019)
MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas
Naema Nayyar et al.
BLOOD ADVANCES (2019)
Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents
Andishe Attarbaschi et al.
BLOOD ADVANCES (2019)
Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray
Diego Villa et al.
BLOOD ADVANCES (2019)
Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013
Sandra Eloranta et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades
Joe S. Mendez et al.
NEURO-ONCOLOGY (2018)
The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1
Yasuo Sugita et al.
NEUROPATHOLOGY (2018)
MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS
Alexander Baraniskin et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma
Aurelie Bruno et al.
NEURO-ONCOLOGY (2018)
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma
Han W. Tun et al.
BLOOD (2018)
Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
Lorenz Thurner et al.
BLOOD (2018)
Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma
Vaios Hatzoglou et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Characterization of genomic alterations in primary central nervous system lymphomas
Soheil Zorofchian et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Cognitive functioning and health-related quality of life in patients with newly diagnosed primary CNS lymphoma: a systematic review
Matthijs van der Meulen et al.
LANCET ONCOLOGY (2018)
Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes
Yangying Zhou et al.
NEOPLASIA (2018)
Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients
Parag Mahale et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma
Yuko Miyasato et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2018)
Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model
Yushi Qiu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
K. Fritsch et al.
LEUKEMIA (2017)
Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015
M. van der Meulen et al.
LEUKEMIA (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Andres J. M. Ferreri et al.
LANCET HAEMATOLOGY (2017)
Updated results of single-agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
Christian Grommes et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma
Hyunsoo Cho et al.
ANNALS OF HEMATOLOGY (2017)
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Michail S. Lionakis et al.
CANCER CELL (2017)
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma
Lakshmi Nayak et al.
BLOOD (2017)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
Genomic characterization of primary central nervous system lymphoma
Kazutaka Fukumura et al.
ACTA NEUROPATHOLOGICA (2016)
The role of whole brain radiation in primary CNS lymphoma
Benjamin Kasenda et al.
BLOOD (2016)
The role of autologous stem cell transplantation in primary central nervous system lymphoma
Andres J. M. Ferreri et al.
BLOOD (2016)
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma-a randomized phase III trial (MATRix)
Elisabeth Schorb et al.
BMC CANCER (2016)
Trends in primary central nervous system lymphoma incidence and survival in the US
Meredith S. Shiels et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Sophie Langner-Lemercier et al.
NEURO-ONCOLOGY (2016)
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
Andres J. M. Ferreri et al.
LANCET HAEMATOLOGY (2016)
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial
Gerald Illerhaus et al.
Lancet Haematology (2016)
TERT promoter mutations in primary central nervous system lymphoma are associated with spatial distribution in the splenium
Aurelie Bruno et al.
ACTA NEUROPATHOLOGICA (2015)
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)-a systematic review and individual patient data meta-analysis
B. Kasenda et al.
ANNALS OF ONCOLOGY (2015)
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
Antonio Omuro et al.
BLOOD (2015)
High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates
Irina Bonzheim et al.
BLOOD (2015)
Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins
Manuel Montesinos-Rongen et al.
JOURNAL OF IMMUNOLOGY (2015)
NIMG-24HIGH SPATIOTEMPORAL DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) PERFUSION MRI USING MULTIBAND ECHOPLANAR IMAGING (MB-EPI)
Benjamin Ellingson et al.
NEURO-ONCOLOGY (2015)
Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma
Stephan Kreher et al.
NEURO-ONCOLOGY (2015)
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial
Antonio Omuro et al.
LANCET HAEMATOLOGY (2015)
The perivascular microenvironment in primary central nervous system lymphomas: the role of chemokines and the endothelin B receptor
Yasuo Sugita et al.
BRAIN TUMOR PATHOLOGY (2015)
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group
Elisa J. Pulczynski et al.
HAEMATOLOGICA (2015)
The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing
I. Vater et al.
LEUKEMIA (2015)
PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL)
Anna Sophie Berghoff et al.
CLINICAL NEUROPATHOLOGY (2014)
Immunoglobulin Repertoire of Primary Lymphomas of the Central Nervous System
Manuel Montesinos-Rongen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
CNS Lymphoma: A Practical Diagnostic Approach
Caterina Giannini et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Mutational analysis of primary central nervous system lymphoma
Aurelie Bruno et al.
ONCOTARGET (2014)
Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYClowBCL2low subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas
Anna Brunn et al.
ACTA NEUROPATHOLOGICA (2013)
Combined Diffusion and Perfusion MR Imaging as Biomarkers of Prognosis in Immunocompetent Patients with Primary Central Nervous System Lymphoma
F. E. Valles et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era
A. M. Evens et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma
James L. Rubenstein et al.
BLOOD (2013)
Acute Cognitive Impairment in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplant
Desiree Jones et al.
CANCER (2013)
Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome
Patrick G. Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
James L. Rubenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A Reappraisal of the Diagnostic and Therapeutic Management of Uncommon Histologies of Primary Ocular Adnexal Lymphoma
Maurilio Ponzoni et al.
ONCOLOGIST (2013)
Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma
Tobias Birnbaum et al.
NEUROLOGY INTERNATIONAL (2013)
Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion- Weighted MRI
Matthew J. Wieduwilt et al.
CLINICAL CANCER RESEARCH (2012)
Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
Alberto Gonzalez-Aguilar et al.
CLINICAL CANCER RESEARCH (2012)
Aquaporin-4 expression in primary human central nervous system lymphomas correlates with tumour cell proliferation and phenotypic heterogeneity of the vessel wall
Beatrice Nico et al.
EUROPEAN JOURNAL OF CANCER (2012)
MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma
Alexander Baraniskin et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center
Mary R. Welch et al.
NEURO-ONCOLOGY (2012)
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging
Ramon F. Barajas et al.
NEURO-ONCOLOGY (2012)
Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma
Chang Ohk Sung et al.
BLOOD (2011)
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BLOOD (2011)
Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
J. L. Villano et al.
BRITISH JOURNAL OF CANCER (2011)
Primary Central Nervous System Lymphomas: A Validation Study of Array-Based Comparative Genomic Hybridization in Formalin-Fixed Paraffin-Embedded Tumor Specimens
Esteban Braggio et al.
CLINICAL CANCER RESEARCH (2011)
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
Peter Kamper et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Ocular involvement in patients with primary CNS lymphoma
Jung Taeck Hong et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Whole-brain radiotherapy in primary CNS lymphoma
Andres J. M. Ferreri et al.
LANCET ONCOLOGY (2011)
Primary intramedullary spinal cord lymphoma
E. P. Flanagan et al.
NEUROLOGY (2011)
Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium
Chi-Chao Chan et al.
ONCOLOGIST (2011)
Mutations of CARD11 but not TNFAIP3 may activate the NF-κB pathway in primary CNS lymphoma
Manuel Montesinos-Rongen et al.
ACTA NEUROPATHOLOGICA (2010)
Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma
R. F. Barajas et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
Laurent Brault et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells
Daniel Venetz et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
Eckhard Thiel et al.
LANCET ONCOLOGY (2010)
Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort
Philipp Kiewe et al.
NEURO-ONCOLOGY (2010)
Primary central nervous system lymphoma: a clinicopathological study of 75 cases
Matthias Preusser et al.
PATHOLOGY (2010)
Retinal Fluorescein, Indocyanine Green Angiography, and Optic Coherence Tomography in Non-Hodgkin Primary Intraocular Lymphoma
Christine Fardeau et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Pathologic Correlates of Primary Central Nervous System Lymphoma Defined in an Orthotopic Xenograft Model
Cigall Kadoch et al.
CLINICAL CANCER RESEARCH (2009)
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study
Hendrik Pels et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma
Jan-Lukas Robertus et al.
MODERN PATHOLOGY (2009)
Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma
H. Schwindt et al.
LEUKEMIA (2009)
Maintenance therapy for central nervous system lymphoma with rituximab
Douglas E. Ney et al.
LEUKEMIA & LYMPHOMA (2009)
Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience
S. Frenkel et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Del(6)(q22) and BCL6 Rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course
Francois M. Cady et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways
M. Booman et al.
JOURNAL OF PATHOLOGY (2008)
Meningeal dissemination in primary CNS lymphoma -: Prospective evaluation of 282 patients
L. Fischer et al.
NEUROLOGY (2008)
Primary CNS lymphoma with intraocular involvement International PCNSL Collaborative Group Report
S. A. Grimm et al.
NEUROLOGY (2008)
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell
M. Montesinos-Rongen et al.
LEUKEMIA (2008)
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly
Antonio M. P. Omuro et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report
S. A. Grimm et al.
ANNALS OF ONCOLOGY (2007)
Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 - Time trends in a 15-year national survey
Ingfrid S. Haldorsen et al.
CANCER (2007)
Angiogenesis in primary central nervous system lymphoma (PCNSL)
Hiroaki Takeuchi et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas
M. Ponzoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines
D. D. Correa et al.
ANNALS OF ONCOLOGY (2007)
CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies
J. E. C. Bromberg et al.
NEUROLOGY (2007)
Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan
Keishi Makino et al.
SURGICAL NEUROLOGY (2006)
Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors
Kristoph Jahnke et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Trends in cancer risk among people with AIDS in the United States 1980-2002
Eric A. Engels et al.
AIDS (2006)
Gene expression and angiotropism in primary CNS lymphoma
JL Rubenstein et al.
BLOOD (2006)
FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up
H Palmedo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
A uniform activated B-cell-like in-immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases
S Camilleri-Broet et al.
BLOOD (2006)
First-line autologous transplantation in stem cell primary CNS lymphoma
M Brevet et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Delayed neurotoxicity in primary central nervous system lymphoma
AMP Omuro et al.
ARCHIVES OF NEUROLOGY (2005)
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma
LE Abrey et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Primary central nervous system lymphomas (PCNSL):: MRI features at presentation in 100 patients
W Küker et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma
PL Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma
K Jahnke et al.
ANNALS OF ONCOLOGY (2005)
Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)
T Wolf et al.
LEUKEMIA & LYMPHOMA (2005)
Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation
M Montesinos-Rongen et al.
BLOOD (2004)
Treatment-induced leukoencephalopathy in primary CNS lymphoma - A clinical and autopsy study
R Lai et al.
NEUROLOGY (2004)
Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment
A Hormigo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Pseudouveitis -: A clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients
SPS Abad et al.
MEDICINE (2004)
Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy
H Pels et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: An intent-to-treat analysis
LE Abrey et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: A multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
K Hoang-Xuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002
AJM Ferreri et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients
P Gonzalez-Gomes et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?
RB Khan et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
A multicenter study of treatment of primary CNS lymphoma
AJM Ferreri et al.
NEUROLOGY (2002)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Primary intracerebral malignant lymphoma: report of 248 cases
B Bataille et al.
JOURNAL OF NEUROSURGERY (2000)